218 related articles for article (PubMed ID: 22110525)
1. Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis.
Yu J; Sun J; Wang SE; Li H; Cao S; Cong Y; Liu J; Ren X
Clin Dev Immunol; 2011; 2011():469135. PubMed ID: 22110525
[TBL] [Abstract][Full Text] [Related]
2. Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells.
Sun J; Yu J; Li H; Yang L; Wei F; Yu W; Liu J; Ren X
J Exp Clin Cancer Res; 2011 Sep; 30(1):82. PubMed ID: 21917155
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
[TBL] [Abstract][Full Text] [Related]
4. Up-regulated expression of indoleamine 2,3-dioxygenase 1 in non-Hodgkin lymphoma correlates with increased regulatory T-cell infiltration.
Liu XQ; Lu K; Feng LL; Ding M; Gao JM; Ge XL; Wang X
Leuk Lymphoma; 2014 Feb; 55(2):405-14. PubMed ID: 23682557
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
Li F; Zhao Y; Wei L; Li S; Liu J
Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
[TBL] [Abstract][Full Text] [Related]
6. The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.
Salmi S; Lin A; Hirschovits-Gerz B; Valkonen M; Aaltonen N; Sironen R; Siiskonen H; Pasonen-Seppänen S
BMC Cancer; 2021 May; 21(1):641. PubMed ID: 34051744
[TBL] [Abstract][Full Text] [Related]
7. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer.
Mansfield AS; Heikkila PS; Vaara AT; von Smitten KA; Vakkila JM; Leidenius MH
BMC Cancer; 2009 Jul; 9():231. PubMed ID: 19604349
[TBL] [Abstract][Full Text] [Related]
9. Expression of indoleamine 2,3-dioxygenase and infiltration of FOXP3+ regulatory T cells are associated with aggressive features of papillary thyroid microcarcinoma.
Ryu HS; Park YS; Park HJ; Chung YR; Yom CK; Ahn SH; Park YJ; Park SH; Park SY
Thyroid; 2014 Aug; 24(8):1232-40. PubMed ID: 24742251
[TBL] [Abstract][Full Text] [Related]
10. Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer.
Nakamura T; Shima T; Saeki A; Hidaka T; Nakashima A; Takikawa O; Saito S
Cancer Sci; 2007 Jun; 98(6):874-81. PubMed ID: 17433037
[TBL] [Abstract][Full Text] [Related]
11. Indoleamine 2,3-dioxygenase and regulatory t cells in intestinal mucosa in children with inflammatory bowel disease.
Sznurkowska K; Żawrocki A; Sznurkowski J; Iżycka-Świeszewska E; Landowski P; Szlagatys-Sidorkiewicz A; Plata-Nazar K; Kamińska B
J Biol Regul Homeost Agents; 2017; 31(1):125-131. PubMed ID: 28337881
[TBL] [Abstract][Full Text] [Related]
12. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells.
Curti A; Pandolfi S; Valzasina B; Aluigi M; Isidori A; Ferri E; Salvestrini V; Bonanno G; Rutella S; Durelli I; Horenstein AL; Fiore F; Massaia M; Colombo MP; Baccarani M; Lemoli RM
Blood; 2007 Apr; 109(7):2871-7. PubMed ID: 17164341
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine 2,3-dioxygenase affects the aggressiveness of intraductal papillary mucinous neoplasms through Foxp3+CD4+CD25+ T cells in peripheral blood.
Ikemoto T; Shimada M; Komatsu M; Yamada S; Saito Y; Mori H; Morine Y; Imura S; Bando Y; Utsunomiya T
Pancreas; 2013 Jan; 42(1):130-4. PubMed ID: 22722263
[TBL] [Abstract][Full Text] [Related]
14. Circulating Zonulin Correlates with Density of Enteroviruses and Tolerogenic Dendritic Cells in the Small Bowel Mucosa of Celiac Disease Patients.
Vorobjova T; Raikkerus H; Kadaja L; Talja I; Uibo O; Heilman K; Uibo R
Dig Dis Sci; 2017 Feb; 62(2):358-371. PubMed ID: 27995404
[TBL] [Abstract][Full Text] [Related]
15. FOXP3+ regulatory T cells and tumoral indoleamine 2,3-dioxygenase expression predicts the carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas.
Kobayashi N; Kubota K; Kato S; Watanabe S; Shimamura T; Kirikoshi H; Saito S; Ueda M; Endo I; Inayama Y; Maeda S; Nakajima A
Pancreatology; 2010; 10(5):631-40. PubMed ID: 21051918
[TBL] [Abstract][Full Text] [Related]
16. Expression of indoleamine 2,3-dioxygenase in pregnant mice correlates with CD4+CD25+Foxp3+ T regulatory cells.
Yu LL; Zhang YH; Zhao FX
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1722-1728. PubMed ID: 28485810
[TBL] [Abstract][Full Text] [Related]
17. IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells.
Curran TA; Jalili RB; Farrokhi A; Ghahary A
Immunobiology; 2014 Jan; 219(1):17-24. PubMed ID: 23891282
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction.
Lee JH; Chen Y; Chan JL; Qian YW; Goydos JS
Cancer Immunol Immunother; 2011 May; 60(5):685-92. PubMed ID: 21327637
[TBL] [Abstract][Full Text] [Related]
19. Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival.
Brody JR; Costantino CL; Berger AC; Sato T; Lisanti MP; Yeo CJ; Emmons RV; Witkiewicz AK
Cell Cycle; 2009 Jun; 8(12):1930-4. PubMed ID: 19448397
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.
Sharma MD; Baban B; Chandler P; Hou DY; Singh N; Yagita H; Azuma M; Blazar BR; Mellor AL; Munn DH
J Clin Invest; 2007 Sep; 117(9):2570-82. PubMed ID: 17710230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]